194 related articles for article (PubMed ID: 32592351)
1. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
[TBL] [Abstract][Full Text] [Related]
2. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
Martini T; Heinkele J; Mayr R; Weis CA; Wezel F; Wahby S; Eckstein M; Schnöller T; Breyer J; Wirtz R; Ritter M; Bolenz C; Erben P
Urol Oncol; 2018 Dec; 36(12):530.e19-530.e27. PubMed ID: 30446441
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients.
Shukla SK; Chandra S; Chauhan N; Sarpal R
J Cancer Res Ther; 2021; 17(4):887-892. PubMed ID: 34528537
[TBL] [Abstract][Full Text] [Related]
5. Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10.
Kumagai-Togashi A; Uozaki H; Kikuchi Y; Watabe S; Numakura S; Watanabe M
Anticancer Res; 2019 Feb; 39(2):635-640. PubMed ID: 30711939
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
[TBL] [Abstract][Full Text] [Related]
7. CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.
Gürel D; Kargı A; Karaman I; Onen A; Unlü M
Pathol Oncol Res; 2012 Apr; 18(2):153-60. PubMed ID: 21681600
[TBL] [Abstract][Full Text] [Related]
8. CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis.
Abdou AG
APMIS; 2007 Nov; 115(11):1206-18. PubMed ID: 18092952
[TBL] [Abstract][Full Text] [Related]
9. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
[TBL] [Abstract][Full Text] [Related]
10. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.
Spradling K; Lotan Y; Shokeir A; Abol-Enein H; Mosbah A; Morgan JB; Ghoneim M; Youssef RF
Urol Oncol; 2016 Sep; 34(9):417.e1-8. PubMed ID: 27157247
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study.
Florianova L; Xu B; Traboulsi S; Elmansi H; Tanguay S; Aprikian A; Kassouf W; Brimo F
World J Surg Oncol; 2015 Nov; 13():317. PubMed ID: 26577765
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.
Elwy AE; Elsaba TM; Abd Elzaher AR; Nassar MI
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3735-3746. PubMed ID: 31870116
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder.
Owyong M; Lotan Y; Kapur P; Panwar V; McKenzie T; Lee TK; Zi X; Martin JW; Mosbah A; Abol-Enein H; Ghoneim M; Youssef RF
Urol Oncol; 2019 Jul; 37(7):478-484. PubMed ID: 30910351
[TBL] [Abstract][Full Text] [Related]
16. High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.
Seiler R; von Gunten M; Thalmann GN; Fleischmann A
Hum Pathol; 2012 Feb; 43(2):269-75. PubMed ID: 21835428
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
Li Z; Wang KE; Zhou XL; Zhou J; Ye CH
Med Sci Monit; 2018 Jan; 24():438-447. PubMed ID: 29358570
[TBL] [Abstract][Full Text] [Related]
18. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
19. CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis.
Huang WB; Zhou XJ; Chen JY; Zhang LH; Meng K; Ma HH; Lu ZF
Jpn J Clin Oncol; 2005 May; 35(5):245-50. PubMed ID: 15886270
[TBL] [Abstract][Full Text] [Related]
20. Role of CD10 Immunohistochemical Expression in Predicting Aggressive Behavior of Phylloides Tumors.
Tariq MU; Haroon S; Kayani N
Asian Pac J Cancer Prev; 2015; 16(8):3147-52. PubMed ID: 25921112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
